OA: Evaluation of a novel ELISA for the tumor-associated antigen CA 72–4 in patients with ovarian cance Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, January 25, 2017

OA: Evaluation of a novel ELISA for the tumor-associated antigen CA 72–4 in patients with ovarian cance



Evaluation of a novel ELISA for the tumor-associated antigen CA 72–4 in patients with ovarian cancer, Future Science OA, Future Science

Lay abstract Cancer antigen 72–4 is a tumor marker for ovarian cancer. It can be measured in blood samples of patients to monitor the disease. We compared an established method of measurement with a newly designed one (DRG TM-CA 72–4 ELISA) and found that the newer one produced reliable results. Therefore, the DRG TM-CA 72–4 ELISA could be an option for the measurement of cancer antigen 72–4 in ovarian cancer patients.

0 comments :

Post a Comment

Your comments?